vs

Side-by-side financial comparison of ICON PLC (ICLR) and LESAKA TECHNOLOGIES INC (LSAK). Click either name above to swap in a different company.

LESAKA TECHNOLOGIES INC is the larger business by last-quarter revenue ($3.0B vs $2.0B, roughly 1.5× ICON PLC). ICON PLC runs the higher net margin — 0.1% vs 0.0%, a 0.1% gap on every dollar of revenue. On growth, ICON PLC posted the faster year-over-year revenue change (0.6% vs 0.2%). Over the past eight quarters, LESAKA TECHNOLOGIES INC's revenue compounded faster (352.8% CAGR vs 0.6%).

ICON plc is an Irish headquartered multinational healthcare intelligence and clinical research organisation. As of February 2025 had approximately 41,900 employees in 55 countries.

Lesaka Technologies is a South-African financial technology company that is listed on the NASDAQ and Johannesburg Stock Exchange. Lesaka’s primary focus is on financial inclusion, offering financial services to previously underserved communities and merchants.

ICLR vs LSAK — Head-to-Head

Bigger by revenue
LSAK
LSAK
1.5× larger
LSAK
$3.0B
$2.0B
ICLR
Growing faster (revenue YoY)
ICLR
ICLR
+0.4% gap
ICLR
0.6%
0.2%
LSAK
Higher net margin
ICLR
ICLR
0.1% more per $
ICLR
0.1%
0.0%
LSAK
Faster 2-yr revenue CAGR
LSAK
LSAK
Annualised
LSAK
352.8%
0.6%
ICLR

Income Statement — Q3 FY2025 vs Q1 FY2027

Metric
ICLR
ICLR
LSAK
LSAK
Revenue
$2.0B
$3.0B
Net Profit
$2.4M
$437.0K
Gross Margin
Operating Margin
4.2%
2.2%
Net Margin
0.1%
0.0%
Revenue YoY
0.6%
0.2%
Net Profit YoY
-98.8%
EPS (diluted)
$0.03

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
ICLR
ICLR
LSAK
LSAK
Q3 26
$3.0B
Q4 25
$178.7M
Q3 25
$2.0B
$171.4M
Q2 25
$2.0B
$168.5M
Q1 25
$2.0B
$161.4M
Q4 24
$176.2M
Q3 24
$2.0B
$153.6M
Q2 24
$2.1B
$146.0M
Net Profit
ICLR
ICLR
LSAK
LSAK
Q3 26
$437.0K
Q4 25
$3.6M
Q3 25
$2.4M
$-4.3M
Q2 25
$183.0M
$-28.4M
Q1 25
$154.2M
$-22.1M
Q4 24
$-32.5M
Q3 24
$197.1M
$-4.5M
Q2 24
$146.9M
$-5.0M
Gross Margin
ICLR
ICLR
LSAK
LSAK
Q3 26
Q4 25
31.4%
Q3 25
30.9%
Q2 25
28.9%
Q1 25
27.5%
Q4 24
25.7%
Q3 24
22.6%
Q2 24
22.6%
Operating Margin
ICLR
ICLR
LSAK
LSAK
Q3 26
2.2%
Q4 25
1.2%
Q3 25
4.2%
0.2%
Q2 25
10.4%
-16.7%
Q1 25
11.0%
0.4%
Q4 24
0.3%
Q3 24
14.1%
-0.0%
Q2 24
10.8%
0.2%
Net Margin
ICLR
ICLR
LSAK
LSAK
Q3 26
0.0%
Q4 25
2.0%
Q3 25
0.1%
-2.5%
Q2 25
9.1%
-16.9%
Q1 25
7.7%
-13.7%
Q4 24
-18.4%
Q3 24
9.7%
-3.0%
Q2 24
6.9%
-3.4%
EPS (diluted)
ICLR
ICLR
LSAK
LSAK
Q3 26
Q4 25
$0.04
Q3 25
$0.03
$-0.05
Q2 25
$2.30
$-0.40
Q1 25
$1.90
$-0.27
Q4 24
$-0.40
Q3 24
$2.36
$-0.07
Q2 24
$1.76
$-0.08

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
ICLR
ICLR
LSAK
LSAK
Cash + ST InvestmentsLiquidity on hand
$468.9M
$1.5B
Total DebtLower is stronger
$3.2B
Stockholders' EquityBook value
$9.3B
Total Assets
$16.5B
$11.5B
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
ICLR
ICLR
LSAK
LSAK
Q3 26
$1.5B
Q4 25
$69.5M
Q3 25
$468.9M
$72.2M
Q2 25
$390.4M
$76.5M
Q1 25
$526.7M
$71.0M
Q4 24
$60.6M
Q3 24
$695.5M
$49.7M
Q2 24
$506.6M
$59.1M
Total Debt
ICLR
ICLR
LSAK
LSAK
Q3 26
$3.2B
Q4 25
$216.8M
Q3 25
$208.1M
Q2 25
$200.8M
Q1 25
$194.7M
Q4 24
$148.7M
Q3 24
$148.5M
Q2 24
$143.2M
Stockholders' Equity
ICLR
ICLR
LSAK
LSAK
Q3 26
Q4 25
$180.6M
Q3 25
$9.3B
$170.4M
Q2 25
$9.6B
$161.6M
Q1 25
$9.5B
$185.2M
Q4 24
$193.3M
Q3 24
$9.8B
$184.2M
Q2 24
$9.6B
$175.9M
Total Assets
ICLR
ICLR
LSAK
LSAK
Q3 26
$11.5B
Q4 25
$704.6M
Q3 25
$16.5B
$652.9M
Q2 25
$16.6B
$653.7M
Q1 25
$16.7B
$649.2M
Q4 24
$640.6M
Q3 24
$17.2B
$551.9M
Q2 24
$17.0B
$558.5M
Debt / Equity
ICLR
ICLR
LSAK
LSAK
Q3 26
Q4 25
1.20×
Q3 25
1.22×
Q2 25
1.24×
Q1 25
1.05×
Q4 24
0.77×
Q3 24
0.81×
Q2 24
0.81×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
ICLR
ICLR
LSAK
LSAK
Operating Cash FlowLast quarter
$387.6M
Free Cash FlowOCF − Capex
$333.9M
FCF MarginFCF / Revenue
16.3%
Capex IntensityCapex / Revenue
2.6%
Cash ConversionOCF / Net Profit
164.59×
TTM Free Cash FlowTrailing 4 quarters
$1.0B

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
ICLR
ICLR
LSAK
LSAK
Q3 26
Q4 25
$-10.9M
Q3 25
$387.6M
$8.9M
Q2 25
$146.2M
$-9.1M
Q1 25
$268.2M
$10.7M
Q4 24
$-9.2M
Q3 24
$402.7M
$-4.1M
Q2 24
$218.6M
$5.7M
Free Cash Flow
ICLR
ICLR
LSAK
LSAK
Q3 26
Q4 25
$-14.8M
Q3 25
$333.9M
$4.9M
Q2 25
$113.9M
$-13.2M
Q1 25
$239.3M
$7.8M
Q4 24
$-15.5M
Q3 24
$359.3M
$-8.1M
Q2 24
$182.3M
$937.0K
FCF Margin
ICLR
ICLR
LSAK
LSAK
Q3 26
Q4 25
-8.3%
Q3 25
16.3%
2.9%
Q2 25
5.6%
-7.8%
Q1 25
12.0%
4.9%
Q4 24
-8.8%
Q3 24
17.7%
-5.3%
Q2 24
8.6%
0.6%
Capex Intensity
ICLR
ICLR
LSAK
LSAK
Q3 26
Q4 25
2.2%
Q3 25
2.6%
2.3%
Q2 25
1.6%
2.4%
Q1 25
1.4%
1.7%
Q4 24
3.6%
Q3 24
2.1%
2.6%
Q2 24
1.7%
3.2%
Cash Conversion
ICLR
ICLR
LSAK
LSAK
Q3 26
Q4 25
-2.99×
Q3 25
164.59×
Q2 25
0.80×
Q1 25
1.74×
Q4 24
Q3 24
2.04×
Q2 24
1.49×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

ICLR
ICLR

Other Customers$681.3M33%
Clients1125$549.4M27%
Clients15$503.3M25%
Clients610$308.8M15%

LSAK
LSAK

Segment breakdown not available.

Related Comparisons